This inventor holds 1 USPTO granted patent. Top assignees: Marine Biomedical Research Institute of Qingdao Co., Ltd., Qingdao Conson Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ting Hu - Innovator in β-Glucan Composition
Introduction
Ting Hu is a notable inventor based in Shandong, China. He has made significant contributions to the field of immunology through his innovative work on β-glucan compositions. His research focuses on developing effective treatments for immune-related diseases.
Latest Patents
Ting Hu holds a patent for a β-glucan composition and its uses. This composition is specifically designed for improving or treating immune-related diseases. The β-glucan features a unique structure with β-1,3 and β-1,6 glucosidic bonds, and a molecular weight ranging from 1-50 kDa. The composition boasts several advantages, including a controllable mass, abundant sources, simple preparation processes, high product purity, and strong biological activity. It is also easy to produce industrially. The resulting water-soluble β-glucan composition demonstrates enhanced antitumor activity and has the potential to be developed into a safe and effective novel drug for treating immune-related diseases and combating tumors.
Career Highlights
Throughout his career, Ting Hu has worked with various organizations, including Qingdao Conson Pharmaceutical Co., Ltd. and Marine Biomedical Research Institute of Qingdao Co., Ltd. His work in these institutions has furthered the development of his innovative β-glucan composition.
Collaborations
Ting Hu has collaborated with several professionals in his field, including Jiejie Hao and Chenyang Zhao. These collaborations have contributed to the advancement of his research and the successful application of his inventions.
Conclusion
Ting Hu is a pioneering inventor whose work on β-glucan compositions has the potential to revolutionize treatments for immune-related diseases. His innovative approach and dedication to research continue to make a significant impact in the field of immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile